Global Genetic Testing Market - 2026-2033

August 2025 | 48 pages | ID: GAF82450ABF8EN
DataM Intelligence

Abstracts

Global Genetic Testing Market reached US$14.72 billion in 2024 and is expected to reach US$54.21 billion by 2033, growing with a CAGR of 15.40% during the forecast period 2026-2033.

The Global Genetic Testing Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Global Genetic Testing Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Product Type

• Consumables*
• Equipment
• Software

By Technology

• Next-Generation Sequencing (NGS)*
• Polymerase Chain Reaction (PCR)
• Fluorescence in Situ Hybridization (FISH Test)
• Others

By Testing Type

• Carrier Testing*
• Prenatal and Newborn Testing
• Preimplantation Testing
• Predictive and presymptomatic testing
• Forensic testing
• Diagnostic Testing
• Others

By Application

• Cancer Diagnosis*
• Genetic Disease Diagnosis
• Cardiovascular Disease Diagnosis
• Others

Regional Analysis for Global Genetic Testing Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Global Genetic Testing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Technology
2.5. Snippet by Testing Type
2.6. Snippet by Application
2.7. Snippet by Region

3. DYNAMICS

3.1. Impacting Factors
  3.1.1. Drivers
    3.1.1.1. Increasing Prevalence of Genetic Disorders and Chronic Diseases
    3.1.1.2. Advances In Next-Generation Sequencing (NGS) and PCR Technologies
    3.1.1.3. XX
  3.1.2. Restraints
    3.1.2.1. High Cost of Genetic Tests and Sequencing Technologies
    3.1.2.2. Ethical and Privacy Concerns Regarding Genetic Data
    3.1.2.3. XX
  3.1.3. Opportunity
    3.1.3.1. Emerging Markets with Untapped Growth Potential
    3.1.3.2. XX
  3.1.4. Impact Analysis

4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

4.1. Market Leaders and Pioneers
  4.1.1. Emerging Pioneers and Prominent Players
  4.1.2. Established leaders with the largest-selling Brand
  4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Case Studies/Ongoing Research
4.5. Regulatory and Reimbursement Landscape
  4.5.1. North America
  4.5.2. Europe
  4.5.3. Asia Pacific
  4.5.4. South America
  4.5.5. Middle East & Africa
4.6. Porter’s Five Forces Analysis
4.7. Supply Chain Analysis
4.8. Patent Analysis
4.9. SWOT Analysis
4.10. Unmet Needs and Gaps
4.11. Recommended Strategies for Market Entry and Expansion
4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13. Pricing Analysis and Price Dynamics
4.14. Key Opinion Leaders

5. GENETIC TESTING MARKET, BY PRODUCT TYPE

5.1. Introduction
  5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
  5.1.2. Market Attractiveness Index By Product Type
5.2. Consumables*
  5.2.1. Introduction
  5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Equipment
5.4. Software

6. GENETIC TESTING MARKET, BY TECHNOLOGY

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  6.1.2. Market Attractiveness Index By Technology
6.2. Next-Generation Sequencing (NGS)*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Polymerase Chain Reaction (PCR)
6.4. Fluorescence in Situ Hybridization (FISH Test)
6.5. Others

7. GENETIC TESTING MARKET, BY TESTING TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Type
  7.1.2. Market Attractiveness Index By Testing Type
7.2. Carrier Testing*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Prenatal and Newborn Testing
7.4. Preimplantation Testing
7.5. Predictive and presymptomatic testing
7.6. Forensic testing
7.7. Diagnostic Testing
7.8. Others

8. GENETIC TESTING MARKET, BY APPLICATION

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  8.1.2. Market Attractiveness Index, By Application
8.2. Cancer Diagnosis*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Genetic Disease Diagnosis
8.4. Cardiovascular Disease Diagnosis
8.5. Others

9. GENETIC TESTING MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  9.1.2. Market Attractiveness Index, By Region
9.2. North America
  9.2.1. Introduction
  9.2.2. Key Region-Specific Dynamics
  9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Type
  9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.2.7.1. U.S.
    9.2.7.2. Canada
    9.2.7.3. Mexico
9.3. Europe
  9.3.1. Introduction
  9.3.2. Key Region-Specific Dynamics
  9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Type
  9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.3.7.1. Germany
    9.3.7.2. U.K.
    9.3.7.3. France
    9.3.7.4. Spain
    9.3.7.5. Italy
    9.3.7.6. Rest of Europe
9.4. South America
  9.4.1. Introduction
  9.4.2. Key Region-Specific Dynamics
  9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Type
  9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.4.7.1. Brazil
    9.4.7.2. Argentina
    9.4.7.3. Rest of South America
9.5. Asia-Pacific
  9.5.1. Introduction
  9.5.2. Key Region-Specific Dynamics
  9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Type
  9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.5.7.1. China
    9.5.7.2. India
    9.5.7.3. Japan
    9.5.7.4. South Korea
    9.5.7.5. Rest of Asia-Pacific
9.6. Middle East and Africa
  9.6.1. Introduction
  9.6.2. Key Region-Specific Dynamics
  9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Type
  9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking

11. COMPANY PROFILES

  11.1.1. Abbott Laboratories*
  11.1.2. Company Overview
  11.1.3. Product Portfolio
    11.1.3.1. Product Description
    11.1.3.2. Product Key Performance Indicators (KPIs)
    11.1.3.3. Historic and Forecasted Product Sales
    11.1.3.4. Product Sales Volume
  11.1.4. Financial Overview
    11.1.4.1. Company Revenue
    11.1.4.2. Geographical Revenue Shares
    11.1.4.3. Revenue Forecasts
  11.1.5. Key Developments
    11.1.5.1. Mergers & Acquisitions
    11.1.5.2. Key Product Development Activities
    11.1.5.3. Regulatory Approvals, etc.
  11.1.6. SWOT Analysis
11.2. BioRad Laboratories Inc
11.3. Illumina Inc
11.4. Myriad Genetics Inc
11.5. Danaher Corporation
11.6. Quest Diagnostics Incorporated
11.7. MedGenome
11.8. LabCorp
11.9. 3billion, Inc
11.10. Blueprint Genetics
LIST NOT EXHAUSTIVE

12. ASSUMPTIONS AND RESEARCH METHODOLOGY

12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation

13. APPENDIX

13.1. About Us and Services
13.2. Contact Us